Stockholm - Delayed Quote SEK

IRLAB Therapeutics AB (publ) (IRLAB-A.ST)

Compare
7.12
-0.64
(-8.25%)
At close: 5:29:44 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
94,628
94,628
5,678
61,136
207,782
Cost of Revenue
--
--
--
--
39,091
Gross Profit
--
--
--
61,136
168,691
Operating Expense
169,739
169,739
175,864
174,359
116,239
Operating Income
-75,111
-75,111
-170,186
-113,223
52,452
Net Non Operating Interest Income Expense
-8,018
-8,018
2,926
-297
-369
Pretax Income
-83,129
-83,129
-177,840
-113,406
51,781
Net Income Common Stockholders
-83,129
-83,129
-177,839
-113,406
51,781
Diluted NI Available to Com Stockholders
-83,129
-83,129
-177,839
-113,406
51,781
Basic EPS
-1.60
-1.60
-3.43
-2.19
1.00
Diluted EPS
-1.60
-1.60
-3.43
-2.19
1.00
Basic Average Shares
51,868.41
51,868.41
51,868.41
51,831.91
51,748.41
Diluted Average Shares
51,868.41
51,868.41
51,868.41
51,831.91
51,748.41
Total Operating Income as Reported
-75,111
-75,111
-180,765
-113,110
52,576
Total Expenses
169,739
169,739
175,864
174,359
155,330
Net Income from Continuing & Discontinued Operation
-83,129
-83,129
-177,839
-113,406
51,781
Normalized Income
-83,129
-83,129
-167,259
-113,406
51,781
Interest Income
2,459
2,459
3,125
--
1
Interest Expense
10,477
10,477
199
297
370
Net Interest Income
-8,018
-8,018
2,926
-297
-369
EBIT
-72,652
-72,652
-177,641
-113,109
52,151
EBITDA
-68,069
-68,069
-173,325
-108,330
55,625
Reconciled Cost of Revenue
--
--
--
--
39,091
Reconciled Depreciation
4,583
4,583
4,316
3,982
3,474
Net Income from Continuing Operation Net Minority Interest
-83,129
-83,129
-177,839
-113,406
51,781
Total Unusual Items Excluding Goodwill
--
--
-10,580
--
--
Total Unusual Items
--
--
-10,580
--
--
Normalized EBITDA
-68,069
-68,069
-162,745
-108,330
55,625
12/31/2021 - 2/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACTI.ST Active Biotech AB (publ)
0.0724
-5.97%
 
EGTX.ST Egetis Therapeutics AB (publ)
4.0250
-6.50%
 
ONCO.ST Oncopeptides AB (publ)
1.6660
-2.34%
 
XBRANE.ST Xbrane Biopharma AB (publ)
0.1800
-4.66%
 
SANION.ST Saniona AB (publ)
5.90
-4.38%
 
BIOA-B.ST BioArctic AB (publ)
169.60
-3.36%
 
PRQR ProQR Therapeutics N.V.
1.1800
-7.09%
 
BCYC Bicycle Therapeutics plc
6.89
-7.27%
 
AFMD Affimed N.V.
0.5701
-9.79%
 
ARWR Arrowhead Pharmaceuticals, Inc.
10.68
-11.44%